Each of these 4 papG molecular variants have distinct receptor binding specificities, and hence understood to confer differences in host range specificities [9–11] and /or capacity to cause specific UTI clinical syndromes [9, 12, 13], albeit some contradicting findings in other studies [14]. The gene discussed is PAPOLG; the disease is bacterial urinary tract infection.